MHRA approves new indication for MSDs Ezetrol
The UKs Medicines and Healthcare products Regulatory Agency MHRA has approved a new indication for MSDs Ezetrol ezetimibe making it available to patients with coronary heart disease CHD and a history...
View ArticleAtorvastatin A Drusen Disintegrator
Can treatment with a highdose statin for agerelated macular degeneration resolve drusen and improve visual acuity Medscape Optometry
View ArticleStroke Rounds Statin Users Have Better Outcomes CMECE
MedPage Today Observation warrants a randomized trial in acute stroke researchers say
View ArticlePoint of Care PoC Lipid Test Market Worth $280.0 Mn By 2022 Grand View...
SAN FRANCISCO February 29 2016 PRNewswire Global point of care PoC lipid test market is expected to reach USD 280.02 million by 2022 according to a new report by Grand View Research Inc. Growing...
View ArticleStatin use does not reduce risk of acute kidney injury following cardiac surgery
Adults who received atorvastatin before during and after cardiac surgery did not have a reduction in the risk of acute kidney injury compared with a placebo group according to a doubleblinded...
View ArticleNew indication for Inegy
Inegy simvastin ezetimibe; Merck Sharp & Dohme is nowÂindicated to reduce the risk of cardiovascular events in patients with coronary heart disease and a history of acute coronary syndrome...
View ArticleCatabasis Pharmaceuticals to Present at Cowen and Companys 36th Annual Health...
Catabasis Pharmaceuticals Inc. NASDAQCATB a clinicalstage biopharmaceutical company today announced that Jill C. Milne Ph.D. Chief Executive Officer will present a corporate and pipeline overview at...
View ArticleAmarin's Right to Promote VascepaR OffLabel Affirmed Under First Amendment...
BEDMINSTER NJ and DUBLIN IRELANDMarketwired March 08 2016 Amarin Corporation plc NASDAQ AMRN announced today settlement terms have been reached among the parties to resolve the Amarin First Amendment...
View ArticleMerck Applauds the U.S. Department of Veterans Affairs VA for Broadening...
Merck NYSEMRK known as MSD outside the United States and Canada applauds the U.S. Department of Veterans Affairs VA for broadening access to treatment for Veterans with chronic hepatitis C virus HCV...
View ArticleTobira Therapeutics TBRA Releases Full Q42015 Results
Brief Update On Thursday March 3 2016 Tobira Therapeutics TBRA released its Q42015 results and held a conference call. The call helped to provide clues regarding the direction and timeline of...
View ArticleStatin Drugs to Aid Heart May Damage Muscle and Kidneys Reports Journal of...
TUCSON Ariz. March 14 2016 PRNewswireUSNewswire &160;Increasing numbers of Americans are being prescribed statin drugs to lower their risk of heart attack or stroke. But the risks of these drugs to...
View ArticleStatins cut tuberculosis treatment time in mice
In a study using mice the Johns Hopkins University School of Medicine infectious disease experts have added to evidence that statin drugsknown primarily for their cholesterollowering effectscan...
View ArticleJury favors Amgen in PCSK9 patent case
A jury upheld two patents from Amgen Inc. NASDAQAMGN covering mAbs against PCSK9 in the company's patent infringement suit against Regeneron Pharmaceuticals Inc. NASDAQREGN and partner
View ArticleStatins may reduce colorectal cancer risk in patients with IBD
Statin use was associated with a reduced risk for colorectal cancer in patients with inflammatory bowel diseases according to a recent study published in Clinical Gastroenterology and Hepatology.Ashwin...
View ArticleIndividualized benefit approach expands statin eligibility
A new individualized benefit approach to prescribing statins has identified approximately 9.5 million lowerrisk Americans who could benefit from statin therapy as a primary prevention of CVD...
View ArticleAmgen To Present Repatha Evolocumab Data At ACC.16
THOUSAND OAKS Calif. March 21 2016 PRNewswire &160;Amgen NASDAQAMGN today announced that it will present 19 abstracts related to its cardiovascular portfolio including new detailed data...
View ArticleRegeneron and Sanofi Announce Positive Topline Results from Phase 3 PraluentÂ...
TARRYTOWN N.Y. and PARIS March 23 2016 PRNewswire &160;Regeneron Pharmaceuticals Inc. NASDAQ REGN and Sanofi today announced positive results from the Phase 3 ODYSSEY ESCAPE trial evaluating...
View ArticlePatent dispute could force Sanofi's Praluent off market
A legal challenge by Amgen against Sanofi and Regeneron could be so successful it could end in its rivals' PCKS9 drug Praluent forced off the market.Amgen has just won its patent case in the Federal...
View ArticleShould Clinicians Change Statin Talks With Patients Study Yes
New "lifespan gain" research shows that in those at risk for CVD most have little gain after a primary prevention intervention and a few have very large gains. But many say they'd...
View Article